Harold G. Selnick

In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α_1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

James C. Barrow, Philippe G. Nantermet, Harold G. Selnick et al. · Journal of Medicinal Chemistry · 2000 · 223 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase

Nigel J. Liverton, John W. Butcher, Christopher F. Claiborne et al. · Journal of Medicinal Chemistry · 1999 · 196 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds

Joanne E. Tomassini, Harold G. Selnick, M E Davies et al. · Antimicrobial Agents and Chemotherapy · 1994 · 188 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Discovery of 6-(Fluoro-¹⁸<i>F</i>)-3-(1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-1-yl)isoquinolin-5-amine ([¹⁸F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)

Abbas Walji, Eric D. Hostetler, Harold G. Selnick et al. · Journal of Medicinal Chemistry · 2016 · 180 citations

Life Sciences, Neurobiology, Neuroscience +17

Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice

Nicholas B. Hastings, Xiaohai Wang, Lixin Song et al. · Molecular Neurodegeneration · 2017 · 154 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17